Patents Assigned to Biomedix, Inc.
-
Publication number: 20050089944Abstract: An amperometric glucose biosensor comprises a sensing electrode and a reference electrode arranged in a side-by-side parallel configuration on an electrically insulating sheet. A passive cover electrode is placed over the side-by-side sensing electrode and reference electrode so that the active surface of the passive cover electrode opposes the active surfaces of the side-by-side electrodes. Physical contact between the passive covering electrode and the side-by-side electrodes is prevented by insulating spacers. The sensing electrode comprises a conductive graphite track coated with a formulation comprising a redox mediator and enzyme and the reference electrode is a parallel track comprising an Ag/AgCl formulation while the passive cover electrode comprising a conductive graphite track coated with a formulation comprising the same redox mediator as used in the sensing electrode but not including an enzyme.Type: ApplicationFiled: October 27, 2003Publication date: April 28, 2005Applicant: BioMedix, Inc.Inventors: Paul Shieh, Ching-Hsin Cho
-
Patent number: 6875744Abstract: Short bioactive peptides containing phenylalanine, leucine, alanine, and lysine residues are disclosed. The peptides can be used in antibacterial, antifungal, anticancer, and other biological applications.Type: GrantFiled: March 28, 2001Date of Patent: April 5, 2005Assignee: Helix BioMedix, Inc.Inventor: Donald R. Owen
-
Patent number: 6740042Abstract: A system and method for simultaneous, bilateral, segmental blood pressure measurement are disclosed. In one illustrative embodiment of the invention, two Doppler modules are configured to operate at nominally the same Doppler carrier frequency so that they probe for substantially the same range of physiological information. However, the Doppler carrier frequencies for the Doppler modules are also sufficiently different to substantially avoid interference between the two modules. A phase-locked loop (PLL) used to demodulate the velocity signals in each Doppler module efficiently blocks interference signals because they have frequencies that are the difference in the Doppler carrier frequencies and that are outside the locking range of the PLL. Broad-band RF amplifiers and Doppler transducers are used to ensure that the frequency responses of the Doppler modules are substantially the same.Type: GrantFiled: September 5, 2002Date of Patent: May 25, 2004Assignee: Biomedix, Inc.Inventors: David A. Lerner, William Lee Rogers
-
Patent number: 6440935Abstract: Inhibition of eucaryotic pathogens and neoplasms and stimulation of lymphocytes and fibroblasts with lytic peptides such as cecropins and sarcotoxins. Eucaryotic cells are contacted with cecropin or sarcotoxin, or a synergistic combination of cecropins or sarcotoxin with lysozyme, in an amount effective to lyse or inhibit the cells. Target cells include eucaryotic microorganisms such as protozoa, e.g. T. cruzi and P. falciparum, mammalian lymphomas and leukemias, and cells infected with intracellular pathogens such as viruses, bacteria and protozoa. Also disclosed is a method for stimulating proliferation of lymphocytes and fibroblasts by contacting such cells with an effective amount of cecropin or sarcotoxin. The methods may be in vitro or in vivo.Type: GrantFiled: October 4, 1999Date of Patent: August 27, 2002Assignee: Helix Biomedix, Inc.Inventors: Jesse M. Jaynes, Frederic M. Enright, Kenneth L. White
-
Publication number: 20020025918Abstract: Novel synthetic lytic and proliferative peptides were designed and constructed to encompass the structural features associated with lytic and proliferative activity. These compounds, along with the human &bgr; fibrin signal peptide share structural and functional properties of the known lytic peptides. These peptides are effective agents in the treatment of microbial infections including gram negative and gram positive bacteria, fungus, virus, yeast, and protozoa, in the lysis of cancer cells, and in the proliferation of fibroblasts and lymphocytes. Additional functions include synergy and use as general adjuvants and in the enhancement of wound healing.Type: ApplicationFiled: July 3, 2001Publication date: February 28, 2002Applicant: Helix BioMedix, Inc.Inventor: Jesse M. Jaynes
-
Patent number: 6303568Abstract: A novel class of antimicrobial agents for animal species including cecropins, attacins, lysozymes, phage derived polypeptides, such as those transcribed from gene 13 of phage 22, an S protein from lambda phage, and an E protein from phage PhiXl74, as well as, synthetically derived polypeptides of similar nature. The antimicrobial agents can be used to treat microbial infections and as components of medicinal compositions. The genes encoding for such antimicrobial agents can be used to transform animal cells, especially embryonic cells. The transformed animals including such antimicrobial cells are also included.Type: GrantFiled: November 14, 1996Date of Patent: October 16, 2001Assignee: Helix Biomedix, Inc.Inventors: Jesse M. Jaynes, Frederick M. Enright, Kenneth L. White
-
Patent number: 6255282Abstract: Novel synthetic lytic and proliferative peptides were designed and constructed to encompass the structural features associated with lytic and proliferative activity. These compounds, along with the human &bgr; fibrin signal peptide share structural and functional properties of the known lytic peptides. These peptides are effective agents in the treatment of microbial infections including gram negative and gram positive bacteria, fungus, virus, yeast, and protozoa, in the lysis of cancer cells, and in the proliferation of fibroblasts and lymphocytes. Additional functions include synergy and use as general adjuvants and in the enhancement of wound healing.Type: GrantFiled: January 15, 1999Date of Patent: July 3, 2001Assignee: Helix Biomedix, Inc.Inventor: Jesse M. Jaynes
-
Patent number: 6033866Abstract: A highly sensitive sensor for the amperometric assay of glucose in aqueous media having a face-to-face sandwich configuration is provided which comprises a sensing electrode strip containing a first redox mediator in an electrically conductive coating and a reference electrode strip in simultaneous contact with a reagent strip containing a second redox mediator which is sandwiched between the active electrode surfaces. An opening is provided in the reference electrode for the introduction of samples. In one embodiment, a whole blood separation membrane is interposed between the reference electrode and the reagent strip to filter red blood cells and other particles from whole blood to enable direct assay of glucose without sample preparation. The sensing electrode comprises a non-conductive support member having an electrically conductive layer containing the first redox mediator.Type: GrantFiled: December 8, 1997Date of Patent: March 7, 2000Assignee: Biomedix, Inc.Inventors: Dingli Guo, Paul Shieh, Esfir Goldberg
-
Patent number: 5962410Abstract: Inhibition of eucaryotic pathogens and neoplasms and stimulation of lymphocytes and fibroblasts with lytic peptides such as cecropins and sarcotoxins. Eucaryotic cells are contacted with cecropin or sarcotoxin, or a synergistic combination of cecropins or sarcotoxin with lysozyme, in an amount effective to lyse or inhibit the cells. Target cells include eucaryotic microorganisms such as protozoa, e.g. T. cruzi and P. falciparum, mammalian lymphomas and leukemias, and cells infected with intracellular pathogens such as viruses, bacteria and protozoa. Also disclosed is a method for stimulating proliferation of lymphocytes and fibroblasts by contacting such cells with an effective amount of cecropin or sarcotoxin. The methods may be in vitro or in vivo.Type: GrantFiled: September 6, 1994Date of Patent: October 5, 1999Assignee: Helix Biomedix, Inc.Inventors: Jesse M. Jaynes, Frederic M. Enright, Kenneth L. White
-
Patent number: 5861478Abstract: Novel synthetic lytic and proliferative peptides were designed and constructed to encompass the structural features associated with lytic and proliferative activity. These compounds, along with the human .beta. fibrin signal peptide share structural and functional properties of the known lytic peptides. These peptides are effective agents in the treatment of microbial infections including gram negative and gram positive bacteria, fungus, virus, yeast, and protozoa, in the lysis of cancer cells, and in the proliferation of fibroblasts and lymphocytes. Additional functions include synergy and use as general adjuvants and in the enhancement of wound healing.Type: GrantFiled: September 6, 1995Date of Patent: January 19, 1999Assignee: Helix Biomedix, Inc.Inventor: Jesse M. Jaynes
-
Patent number: 5779867Abstract: A self contained glucose sensor is provided that generally comprises a strip type glucose sensing electrode having an active surface comprising an organic conducting redox salt dispersed in a polymeric membrane, with the membrane coating a conductive strip and a strip type Ag/AgCl reference electrode having its active surface separated from physical contact with the strip type glucose sensor and a carrier strip of water absorbent paper or film containing an enzyme system and an oxidizable dye. The water absorbent carrier strip is in simultaneous contact with both the active surface of the strip type glucose electrode and the active surface of the strip type reference electrode. When an aqueous solution containing glucose is brought in contact with the carrier strip containing the enzyme system an electrical potential, proportional to the concentration of glucose in the solution, is created which can be detected by an electrometer or other suitable device.Type: GrantFiled: May 31, 1996Date of Patent: July 14, 1998Assignee: Biomedix, Inc.Inventor: Paul Shieh
-
Patent number: 5695947Abstract: A sensor for the amperometric assay of cholesterol is provided which comprises a sensing electrode containing a first redox mediator and a reference electrode in simultaneous contact with a reagent strip containing a second redox mediator. The presence of the second redox mediator greatly amplifies the current flow produced by the presence of cholesterol and produces linear correlation of current flow with concentration over an extended range. The sensing electrode comprises a non-conductive support member having an electrically conductive layer containing the first redox mediator. The reference electrode is typically a Ag/AgCl electrode formed by coating an ink containing Ag/AgCl dispersed in a resin on a non-conductive base.Type: GrantFiled: June 6, 1995Date of Patent: December 9, 1997Assignee: Biomedix, Inc.Inventors: Dingli Guo, Paul Shieh, Shek-Hong Lau, Shu-Hui Chen
-
Patent number: 5645710Abstract: A redox electrode for the rapid detection of glucose in aqueous media and a method for its use are provided. The redox electrode comprises an electrically conductive member such as copper, and a redox membrane in direct contact with said electrically conductive member. The redox membrane comprises a polymer matrix such as PVC containing a plasticizer, and a complex of 7,7,8,8-tetracyanoquinodimethane and tetrathiafulvalene with the complex having a burgundy-red coloration and characterized by a broad absorption from about 340 nm to about 550 nm and weaker absorption between about 650 nm to about 800 nm having about six small peaks with an absorption maximum at about 750 nm. Glucose is rapidly assayed by bringing the redox electrode and a reference electrode into simultaneous contact with an aqueous medium containing KCl, phosphate buffer, glucose oxidase, peroxidase, and 3,3',5,5'-tetramethylbenzidine dihydrochloride. The potential of the redox membrane is then monitored until it is stable.Type: GrantFiled: March 18, 1996Date of Patent: July 8, 1997Assignee: Biomedix, Inc.Inventor: Paul Shieh
-
Patent number: 5522977Abstract: A redox electrode for the rapid detection of glucose in aqueous media and a method for its use are provided. The redox electrode comprises an electrically conductive member such as copper, and a redox membrane in direct contact with said electrically conductive member. The redox membrane comprises a polymer matrix such as PVC containing a plasticizer, and a complex of 7,7,8,8 -tetracyanoquinodimethane and tetrathiafulvalene with the complex having a burgundy-red coloration and characterized by a broad absorption from about 340 nm to about 550 nm and weaker absorption between about 650 nm to about 800 nm having about six small peaks with an absorption maximum at about 750nm. Glucose is rapidly assayed by bringing the redox electrode and a reference electrode into simultaneous contact with an aqueous medium containing KCl, phosphate buffer, glucose oxidase, peroxidase, and 3,3',5,5'-tetramethylbenzidine dihydrochloride. The potential of the redox membrane is then monitored until it is stable.Type: GrantFiled: October 7, 1994Date of Patent: June 4, 1996Assignee: Biomedix, Inc.Inventor: Paul Shieh
-
Patent number: 5401377Abstract: An ion-selective electrode having an ion-selective membrane in direct contact with an electrical conductor is provided in which the membrane coats an uninsulated zone surrounded by insulation on the surface of a conductor which is coated with a layer of electrical insulation. The membrane overlays the insulation surrounding the insulation free zone and comprises a polymer which is generally of sufficiently similar composition to that comprising the electrical insulation layer so that it adheres to the insulation forming a membrane with increased structural strength. Embodiments of the electrode containing phosphatidylcholine in the ion-selective membrane have increased sensitivity.Type: GrantFiled: August 6, 1993Date of Patent: March 28, 1995Assignee: Biomedix, Inc.Inventors: Paul Shieh, Dingli Guo, Shek-Hong Lau